BONESUPPORT HOLDING AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228.8 SEK | -0.17% |
|
-1.38% | +21.57% |
| Apr. 25 | Transcript : Bonesupport Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Bonesupport Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presentation Operator MessageOperator (Operator)Welcome to.
Welcom...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Sector
Pharmaceuticals
Calendar
2024-05-14
- Malvern Diabetic Foot Conference
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
228.8
SEK
Average target price
292.7
SEK
Spread / Average Target
+27.91%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +21.57% | 1.39B | |
| +1.45% | 40.51B | |
| -15.94% | 31.67B | |
| +52.66% | 24.62B | |
| -14.50% | 15.65B | |
| -14.38% | 12.07B | |
| -9.12% | 11.97B | |
| -42.56% | 11.61B | |
| +4.87% | 8.81B | |
| -4.33% | 8.5B |
- Stock Market
- Equities
- BONEX Stock
- News Bonesupport Holding AB
- Transcript : Bonesupport Holding AB, Q1 2024 Earnings Call, Apr 25, 2024
